Late Breaking Data: Long-Term Safety and Efficacy of Nemolizumab for AD
Galderma unveils promising long-term data on nemolizumab for atopic dermatitis, showcasing significant skin improvement and quality of life enhancements.
Related Articles
Patient Considerations for New Systemic Treatments for Prurigo Nodularis
A collection of clinical insights on prurigo nodularis, exploring awareness and educational efforts as well as trends in treatment.
Hair & Scalp Disorders: The RX Pad and Beyond Virtual Event
Hair and scalp disorders are among the most common yet challenging conditions in dermatology, often leaving providers searching for more effective, evidence-based treatment strategies. Hair…
Late-Breaking Data: Positive Outcomes in Patients With Skin of Color With AD Using Dupilumab
At RAD 2025, the DISCOVER trial showed that dupilumab monotherapy significantly improved moderate to severe AD symptoms in this patient population.
Acne Archives – JDDonline – Journal of Drugs in Dermatology
Acne Awareness Month: Spotlight on Innovation, Impact, and Individualized Care June is Acne Awareness Month, a timely reminder that acne vulgaris is more than a…
Adam Friedman, MD, FAAD: Spotlighting Disparities in Lichen Planus Screening and Treatment
Friedman discusses survey findings revealing inconsistent screening, outdated assumptions, and lack of FDA-approved therapies for lichen planus.
Visible Light Protection: Needs and Strategies for Diverse Patients
New research highlights the importance of tinted sunscreens with iron oxides for effective protection against visible light-induced skin pigmentation, especially for darker skin tones.
Environmental Factors Play a Major Role in Atopic Dermatitis
Dr Peter Lio explained how pollution, modern lifestyle, and even hygiene products are damaging the skin barrier and fueling the rise in atopic diseases like…
Nonlesional Skin and Blood Interferon Scores Among Patients With a History of Cutaneous Lupus
This cross-sectional study compares nonlesional skin and peripheral blood mononuclear cell interferon-stimulated gene expression in patients with lupus with and without a history of cutaneous…
